Kimbell Royalty Partners, LP (KRP) Misses Q2 EPS by 5c, Slight Beat on Revenues
- Nasdaq closes lower as chipmaker Micron's warning renews tech rout
- Citi’s Top Equity Strategist Warns Analysts are Too Bullish on Stocks
- Bank of America Clients Continue to Buy the Rally, New Data Shows
- Novavax (NVAX) Crashes 30% After a Deep Guidance Cut, Analyst 'Frustrated'
- 'Hard to Say' Whether Current Crypto Bear Market is Over - Morgan Stanley
Get inside Wall Street with StreetInsider Premium. Claim your 1-week free trial here.
Kimbell Royalty Partners, LP (NYSE: KRP) reported Q2 EPS of $0.08, $0.05 worse than the analyst estimate of $0.13. Revenue for the quarter came in at $11.25 million versus the consensus estimate of $11.16 million.
"This was a very exciting and transformative quarter for our company," said Robert Ravnaas, Chairman and Chief Executive Officer of Kimbell Royalty Partners' general partner.
"In mid-July, we closed the Haymaker Acquisition. This was a transformational acquisition for our company, and we are already pleased with the recent performance of the related acreage. Following the Haymaker Acquisition, we expect our distributable cash flow per unit will continue to increase, and as of August 1, 2018, we had 72 rigs actively working on our combined properties
"Our unitholders benefitted from our continued strong financial performance through an increase in our second quarter distribution, which is our fifth consecutive increase since our initial public offering in February 2017. During the second quarter, crude oil pricing increased, although a decline in pricing for NGLs and natural gas resulted in flat overall pricing for the quarter. Average daily production was also essentially flat versus the first quarter but increased 18% compared to the second quarter a year ago. We expect to begin benefitting from production related to the assets acquired in the Haymaker Acquisition in the third quarter," Mr. Ravnaas said.
For earnings history and earnings-related data on Kimbell Royalty Partners, LP (KRP) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Halozyme Therapeutics (HALO) Tops Q2 EPS by 6c, Offers Guidance
- PLAYSTUDIOS, Inc (MYPS) Tops Q2 EPS by 5c
- ClearPoint Neuro, Inc. (CLPT) Misses Q2 EPS by 16c
Create E-mail Alert Related CategoriesEarnings, Management Comments
Related EntitiesCrude Oil, Earnings, Definitive Agreement, IPO
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!